 |
 |

Does Chlamydia pneumoniae Cause Atherosclerosis?
J. Thomas Grayston, MD
Arch Surg. 1999;134:930-934.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
INTRODUCTION
This presentation will be in 3 parts. First, there will be an introduction to the microbiology and epidemiology of Chlamydia pneumoniae. I will then present the data that establish an association between C pneumoniae and atherosclerosis, and finally, I will discuss some of the preliminary data concerning a causal role for C pneumoniae and atherosclerosis.
C PNEUMONIAE, A NEWLY DESCRIBED SPECIES OF THE GENUS CHLAMYDIA
History
We isolated the prototype C pneumoniae strain, TW-183, in 1965, but its role in respiratory infection was not demonstrated until the 1980s.1-2 The laboratory designation of the first isolate from respiratory disease was AR-39 and led to the strain name TWAR (from the TW + AR of the first 2 isolates). In 1989, based on DNA homology and morphology of the elementary body, the TWAR organism was established as a new third species of the genus Chlamydia and named C pneumoniae after the most commonly recognized clinical syndrome associated with . . . [Full Text of this Article] Microbiology Epidemiology
OBSERVATIONAL STUDIES PROVE THE ASSOCIATION OF C PNEUMONIAE AND ATHEROSCLEROSIS
Seroepidemiologic Study Direct Demonstration of C pneumoniae in Atherosclerotic Lesions
ETIOLOGIC STUDIES
Animal Models Mechanisms Antibiotic Treatment Trials Retrospective Studies. Prospective Studies.
CONCLUSIONS
From the Department of Epidemiology, University of Washington, Seattle.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Chlamydia pneumoniae Serology Is Associated With Thrombosis-Related but Not With Plaque-Related Microembolization During Carotid Endarterectomy
Vainas et al.
Stroke 2002;33:1249-1254.
ABSTRACT
| FULL TEXT
Expression of Chlamydia pneumoniae Polymorphic Membrane Protein Family Genes
Grimwood et al.
Infect. Immun. 2001;69:2383-2389.
ABSTRACT
| FULL TEXT
Closing in on Chlamydia and its intracellular bag of tricks
Bavoil et al.
Microbiology 2000;146:2723-2731.
FULL TEXT
Secondary Prevention Antibiotic Treatment Trials for Coronary Artery Disease
Grayston
Circulation 2000;102:1742-1743.
FULL TEXT
Infectious Agents Are Not Necessary for Murine Atherogenesis
Wright et al.
J. Exp. Med. 2000;191:1437-1442.
ABSTRACT
| FULL TEXT
Association Between Polymorphism in the Chemokine Receptor CX3CR1 and Coronary Vascular Endothelial Dysfunction and Atherosclerosis
McDermott et al.
Circ. Res. 2001;89:401-407.
ABSTRACT
| FULL TEXT
|